title: [Research Progression of Maintenance Therapy in Small Cell Lung Cancer].
abstract: Lung cancer is one of the common malignant tumors in the world, the incidence of small cell lung cancer is about 15% among them. Small cell lung cancer is highly sensitive to first-line chemotherapy, but most of the patients relapse after the first-line therapy quickly. Despitemany clinical researchof chemotherapy, biological agents and molecular targeting agents since the 1980s, there still remains a substantial lack of consensus regarding the appropriate therapeutic management on maintenance therapy of small cell lung cancer. The review focuses on maintenance therapy of small cell lung cancer.
authors.affiliation: Department of Medical Oncology, Zhejiang Provincial Cancer Hospital, Hangzhou 310053, China.
authors.forename: Yunyun
authors.initials: Y
authors.lastname: Lu
authors.affiliation: Department of Medical Oncology, Zhejiang Provincial Cancer Hospital, Hangzhou 310053, China.
authors.forename: Yun
authors.initials: Y
authors.lastname: Fan
mesh_terms: D006801:Humans; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000276:immunology; D060046:Maintenance Chemotherapy / Q000379:methods*; D058990:Molecular Targeted Therapy; D055752:Small Cell Lung Carcinoma / Q000188:drug therapy* / Q000276:immunology